Qiagen N.V. Common Shares (QGEN)

R&D Expenses

$50.43M

Quarterly · Period ending: · USD

QGEN logo

QGEN R&D Expenses

Latest reported$50.43M
QGEN Quarterly R&D Expenses ($1.30M → $50.43M)
High-resolution chart · PNG

QGEN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Qiagen N.V. Common Shares R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
50,429,000
48,261,000
47,235,000
48,748,000
47,750,000
43,783,000
48,605,000
44,453,000
49,103,000
51,333,000
45,966,000
47,934,000
49,893,000
54,718,000
44,719,000
48,868,000
49,896,000
46,376,000
42,113,000
48,268,000
52,150,000
47,433,000
46,345,000
36,097,000
31,818,000
34,813,000
33,988,000
41,845,000
40,827,000
40,788,000
40,667,000
42,030,000
39,633,000
39,522,000
40,944,000
38,429,000
38,787,000
37,830,000
58,511,000
36,202,000
42,120,000
39,759,000
39,710,000
35,568,000
33,575,000
38,328,000
43,920,000
41,461,000
37,909,000
40,336,000
43,792,000
34,340,000
33,639,000
34,300,000
32,211,000
31,008,000
30,621,000
28,637,000
32,814,000
32,646,000
32,508,000
32,667,000
34,039,000
30,980,000
29,423,000
31,597,000
30,560,000
26,747,000
24,950,000
25,643,000
28,050,000
24,073,000
23,840,000
21,369,000
22,844,000
17,870,000
12,690,000
11,531,000
11,012,000
10,125,000
10,235,000
10,188,000
10,749,000
8,877,000
9,421,000
10,053,000
7,889,000
7,641,000
9,257,000
9,372,000
9,119,000
7,538,000
7,622,000
7,510,000
7,688,000
7,310,000
6,743,000
6,436,000
6,944,000
6,125,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.